American Oncology Institute
American Oncology Institute operates 17 multi-disciplinary cancer hospitals across India and Sri Lanka, delivering radiation, medical, surgical, and hemato-oncology services under US-standardized clinical protocols. The chain is owned by Siemens Healthineers (via CTSI/Varian) and is currently being divested at a ₹1,500-2,000 crore valuation.
- Company typePrivate
- Founded2012
- HeadquartersHyderabad, India
- Headcount1,001–5,000
- GTM typeB2C
- OfferingServices
What American Oncology Institute does
American Oncology Institute (AOI) is a multi-disciplinary oncology hospital network operating 17 cancer treatment facilities across India and Sri Lanka, with corporate headquarters in Hyderabad. The chain provides comprehensive cancer care spanning radiation oncology, medical oncology, surgical oncology, hemato-oncology and bone marrow transplantation (BMT), pediatric hemato-oncology, nuclear medicine, palliative medicine, pain management, and clinical oncology. AOI's geographic footprint covers 16 Indian cities (tier-2/3 markets such as Hisar, Jammu, Jalandhar, Ludhiana, Aligarh, Imphal, Nagpur, Coimbatore, and Guntur alongside metros Hyderabad and Gurugram) and one facility in Colombo, Sri Lanka, positioning it as the largest and fastest-growing dedicated oncology network in South Asia.
The platform is built on US university-standardized clinical protocols implemented through a Centralized Treatment Planning function and reviewed by an International Tumor Board. Its technology stack includes robotic-assisted surgery featuring a Triple ICG (Indocyanine Green) Fluorescence-Guided technique for esophageal cancer resections, and PET-CT imaging deployed at 12+ hospital locations for diagnosis, staging, and treatment monitoring. Service lines are supported by a diagnostic imaging suite, cancer screening programs, second opinion services, and online consultations, with the combination of standardized SOPs, advanced hardware, and multi-disciplinary case review serving as the basis of clinical differentiation against standalone oncology practices.
AOI operates a direct-to-patient fee-for-service model, with revenue generated from treatment delivery, diagnostics, surgical procedures, and BMT. Patient acquisition runs through a multi-channel mix including a 24/7 call center, WhatsApp support, online appointment booking, second-opinion requests, cancer screening campaigns, and a dedicated international patient services vertical. AOI is a wholly-owned subsidiary of Cancer Treatment Services International (CTSI), itself a subsidiary of Varian Medical Systems Inc., in turn owned by Siemens Healthineers. Siemens is currently running a divestiture process for AOI at a deal value of ₹1,500-2,000 crore with Alvarez & Marsal advising, and non-binding bids expected by end of June.
American Oncology Institute firmographics
Firmographics- Name
- American Oncology Institute
- Legal name
- Cancer Treatment Services International (CTSI)
- Website
- https://americanoncology.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- American Oncology Institute operates 17 multi-disciplinary cancer hospitals across India and Sri Lanka, delivering radiation, medical, surgical, and hemato-oncology services under US-standardized clinical protocols. The chain is owned by Siemens Healthineers (via CTSI/Varian) and is currently being divested at a ₹1,500-2,000 crore valuation.
- Ownership category
- akta.pro rank
American Oncology Institute industry classification
Industry- Product category
- Oncology Hospital Services
- NAICS
- Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)
- SIC
- Services-Hospitals (8060), Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- Oncology & Cancer Specialty Hospitals (HLAFAHAC)
- akta.pro secondary industries
- Medical Oncology (HLAKAFAB), Radiation Oncology (HLAKAFAC), Surgical Oncology (HLAKAFAG), Oncology Telemedicine Platforms (HLALAGAH)
Keywords
Where American Oncology Institute is headquartered
LocationHeadquarters
- HQ city
- Hyderabad
- HQ country
- India
- HQ region
- Asia
Offices18 records
Markets served
American Oncology Institute business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales
Revenue model
- Cancer Treatment Services: Direct healthcare service delivery through hospital network offering oncology treatments including radiation therapy, chemotherapy, surgical oncology, stem cell transplants, and related medical services
- Diagnostic Services: PET-CT scans, pathology, imaging, and laboratory diagnostic services across hospital locations
Go-to-market motion1 record
Distribution channels1 record
Marketing channels7 records
American Oncology Institute product offering
Product offeringCore offering
American Oncology Institute (AOI) operates a multi-disciplinary oncology hospital network across South Asia, delivering comprehensive cancer diagnosis, treatment, and supportive care through 17 hospitals in India and Sri Lanka. Core offerings span radiation oncology, medical oncology, surgical oncology, hemato-oncology and bone marrow transplant, nuclear medicine, palliative care, and pain management. Services are delivered under US university-standardized clinical protocols, with centralized treatment planning, an International Tumor Board for complex cases, and advanced technologies including PET-CT imaging and robotic-assisted surgery.
Product overview
American Oncology Institute (AOI) operates a multi-disciplinary oncology hospital network across South Asia, offering comprehensive cancer care through 17 hospitals in India and Sri Lanka. The platform provides an integrated suite of treatment services including Radiation Oncology, Medical Oncology, Surgical Oncology (with advanced robotic surgery capabilities), Hemato Oncology & BMT, Nuclear Medicine, and PET-CT diagnostic imaging across all locations. AOI differentiates itself through international treatment protocols aligned with US university standards, centralized treatment planning, and multi-disciplinary tumor boards. The organization functions as a subsidiary of Cancer Treatment Services Hyderabad (CTSH), which is part of Varian Medical Systems Inc (a Siemens Healthineers company), with services spanning from preventive screening and second opinions through advanced surgical and medical treatments to palliative care.
Differentiator
Problem solved
Functional benefit
Products and services
- Radiation Oncology Cancer treatment using high-energy radiation to target and destroy cancer cells' DNA, applicable across multiple cancer types including breast, head and neck, cervical, and prostate cancers. Targeted at patients requiring radiation-based oncology care.
- Medical Oncology Chemotherapy and targeted therapy services for cancer treatment, including immunotherapy and hormonal therapy delivered by medical oncologists. Targeted at patients with solid tumors and hematologic malignancies.
- Surgical Oncology Surgical interventions for tumor removal including robotic-assisted surgeries, with capabilities for complex procedures such as robotic esophagectomy. Targeted at patients requiring surgical resection of tumors.
- Hemato Oncology & BMT Blood cancer treatment including leukemia, lymphoma, myeloma along with bone marrow transplantation services for adults and pediatric patients. Targeted at patients with hematologic malignancies requiring bone marrow transplant.
- Paediatric Hemato Oncology & BMT Specialized cancer care and bone marrow transplantation for pediatric patients with blood cancers and related conditions. Targeted at children with hematologic malignancies.
- Nuclear Medicine Diagnostic imaging services including PET-CT scans for cancer detection, staging, and treatment planning across multiple hospital locations. Targeted at patients requiring advanced imaging for cancer diagnosis.
- PET-CT Scan Services Positron Emission Tomography combined with CT scanning for cancer diagnosis, staging, and treatment monitoring available at multiple AOI locations. Targeted at cancer patients and referring physicians needing advanced imaging.
- Pain Management Specialized pain management services for cancer patients to address treatment-related pain and improve quality of life. Targeted at cancer patients experiencing pain from disease or treatment.
- Palliative Medicine Palliative care services focused on symptom management and quality of life improvement for advanced cancer patients. Targeted at patients with advanced-stage disease requiring end-of-life and symptom-focused care.
- Clinical Oncology Comprehensive clinical oncology services providing diagnosis, treatment planning, and management across all cancer types. Targeted at patients seeking end-to-end oncology clinical management.
- Anaesthesia & Critical Care Anaesthesia and critical care services supporting complex oncology surgeries and ICU-level patient management. Targeted at patients undergoing major surgical oncology procedures and those requiring intensive care.
- Cancer Screening Services Early detection and screening services for various cancer types to identify cancer at initial stages when treatment is most effective. Targeted at asymptomatic individuals and at-risk populations for preventive screening.
- Second Opinion Service Expert second opinion consultations for cancer diagnosis and treatment planning, allowing patients to secure their health decisions with additional specialist input. Targeted at patients seeking confirmation or alternative treatment recommendations.
- Online Consultation Digital consultation services allowing patients to connect with AOI oncologists remotely for initial assessments and follow-up consultations. Targeted at patients seeking remote specialist access.
- International Patient Services Specialized services for international patients seeking cancer treatment in India, including treatment planning and coordination. Targeted at cross-border medical tourists seeking affordable, internationally-standardized oncology care.
- Triple ICG Fluorescence-Guided Robotic Surgery Advanced robotic esophageal cancer surgery technique integrating Indocyanine Green (ICG) fluorescence navigation with robotic technology, providing real-time visualization of tumors, blood supply, and anatomical structures for precise tumor resections. Targeted at esophageal cancer patients requiring high-precision surgical oncology.
Quantifiable outcome
- Real-time tumor visualization enabling more precise tumor resections with enhanced safety and oncological outcomes
Companies that use American Oncology Institute
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles2 records
American Oncology Institute technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
American Oncology Institute partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Alvarez & MarsalsupportingInvestment bank engaged by Siemens Healthineers to advise on the planned exit from American Oncology Institute, valued at ₹1,500-2,000 crore
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
American Oncology Institute competitors and assessment
Company assessmentBroad incumbents
- Medanta - The Medicity: Major multi-specialty tertiary care hospital group with established cancer care programs including radiation oncology, surgical oncology, and BMT. Competes for complex oncology referrals in North India, with overlapping clinical capabilities but broader specialty mix than AOI.
- Manipal Hospitals: One of India's largest hospital networks with multi-city presence and oncology service lines. Overlaps with AOI in metro and Tier-2 footprint and cancer care capabilities, but operates as a broad-spectrum health system rather than an oncology specialist.
- Fortis Healthcare: Large multi-specialty hospital network in India with established oncology departments across multiple cities. Competes with AOI for cancer referrals, particularly in North India (Punjab, Haryana, NCR), but oncology is part of a broader hospital portfolio rather than the company's specialty focus.
- Narayana Health: Large multi-specialty hospital chain with growing oncology services including the Mazumdar Shaw Cancer Centre. Competes with AOI on complex cancer care and price-value positioning, particularly in South India, though cancer is one of multiple specialties within a broader network.
- Max Healthcare: Leading North India multi-specialty hospital chain with a dedicated oncology program serving the same geographies as AOI (Delhi NCR, Punjab, Haryana). Comparable on cancer care delivery, technology, and patient demographics, though oncology is one of several verticals.
- Apollo Hospitals Enterprise: India's largest multi-specialty hospital chain with comprehensive oncology programs across many cities. Overlaps with AOI in radiation, medical, and surgical oncology and competes for the same complex cancer referrals, but operates as a broad incumbent rather than a cancer-only specialist.
- Aster DM Healthcare: Multi-geography hospital and clinic operator with material India presence including oncology offerings. Comparable on hospital-based specialty care delivery and outpatient oncology revenue mix, but operates across multiple countries and verticals rather than focusing on cancer specialty.
- Tata Memorial Hospital: Premier government-subsidized cancer specialty hospital in India, widely considered the gold standard for oncology care. Sets clinical reference protocols for the Indian oncology ecosystem and is a credible alternative to AOI, particularly for cost-sensitive patients, though operates on a public-subsidy model rather than for-profit commercial model.
Direct peers
- Cytecare Cancer Hospitals: A focused oncology hospital chain in India providing multi-disciplinary cancer care (medical, surgical, radiation, hemato-oncology) with an organ-site specialty approach. Comparable to AOI as a specialty-only oncology network targeting similar patient segments and complexity tier.
- Healthcare Global Enterprises (HCG): India's largest dedicated oncology hospital chain operating a multi-city network of cancer specialty hospitals with radiation, medical, and surgical oncology plus diagnostics. HCG is the closest direct competitor and has been approached as a strategic bidder for AOI, making it the most analogous operating model.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
American Oncology Institute social profiles
Digital presenceAmerican Oncology Institute financial estimates
Financial estimateRevenue estimate
Valuation estimate
American Oncology Institute leadership team
Management profileNumber of profiles
Profiles2 records
American Oncology Institute funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
American Oncology Institute M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about American Oncology Institute
What does American Oncology Institute do?
American Oncology Institute (AOI) operates a multi-disciplinary oncology hospital network across South Asia, delivering comprehensive cancer diagnosis, treatment, and supportive care through 17 hospitals in India and Sri Lanka. Core offerings span radiation oncology, medical oncology, surgical oncology, hemato-oncology and bone marrow transplant, nuclear medicine, palliative care, and pain management. Services are delivered under US university-standardized clinical protocols, with centralized treatment planning, an International Tumor Board for complex cases, and advanced technologies including PET-CT imaging and robotic-assisted surgery.
Is American Oncology Institute a public or private company?
American Oncology Institute is a private company. It is classified as corporate owned and is currently operating.
When was American Oncology Institute founded?
American Oncology Institute was founded in 2012. It employs 1,001 to 5,000 people.
Where is American Oncology Institute based?
American Oncology Institute is headquartered in Hyderabad, India, in the Asia region.
How does American Oncology Institute make money?
Two revenue lines are on record. Cancer Treatment Services are the primary driver. The others are diagnostic Services.
Who are American Oncology Institute's main competitors?
Broad incumbents on record are Medanta - The Medicity, Manipal Hospitals, Fortis Healthcare, Narayana Health, Max Healthcare, Apollo Hospitals Enterprise, Aster DM Healthcare and Tata Memorial Hospital. Direct peers are Cytecare Cancer Hospitals and Healthcare Global Enterprises (HCG).
Does American Oncology Institute have an API?
No public API is recorded for American Oncology Institute.
What industry is American Oncology Institute in?
American Oncology Institute's product category is Oncology Hospital Services. Its primary akta.pro industry code is HLAFAHAC, Oncology & Cancer Specialty Hospitals, with a secondary code of HLAKAFAB, Medical Oncology. Its NAICS code is 622310 and its SIC code is 8060.